Compare · MAS vs POAI
MAS vs POAI
Side-by-side comparison of Masco Corporation (MAS) and Predictive Oncology Inc. (POAI): market cap, price performance, sector, and recent activity on the wire.
Summary
- MAS operates in Industrials, while POAI operates in Health Care - the two are in different parts of the market.
- MAS is the larger of the two at $14.60B, about 1176.5x POAI ($12.4M).
- Over the past year, MAS is up 8.9% and POAI is down 61.1% - MAS leads by 69.9 points.
- MAS has hit the wire 2 times in the past 4 weeks while POAI has been quiet.
- MAS has more recent analyst coverage (25 ratings vs 2 for POAI).
- Company
- Masco Corporation
- Predictive Oncology Inc.
- Price
- $71.08-1.73%
- $5.49-0.18%
- Market cap
- $14.60B
- $12.4M
- 1M return
- +0.69%
- -16.18%
- 1Y return
- +8.87%
- -61.06%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 2
- 0
- Recent ratings
- 25
- 2
Masco Corporation
Masco Corporation designs, manufactures, and distributes home improvement and building products in North America, Europe, and internationally. The company operates through two segments, Plumbing Products and Decorative Architectural Products. The Plumbing Products segment offers faucets, showerheads, handheld showers, valves, bath hardware and accessories, bathing units, shower bases and enclosures, sinks, toilets, acrylic tubs, shower trays, spas, exercise pools, and fitness systems; brass, copper, and composite plumbing system components; connected water products; thermoplastic solutions, extruded plastic profiles, specialized fabrications, and PEX tubing products; and other non-decorative plumbing products. This segment provides its products under the DELTA, BRIZO, PEERLESS, HANSGROHE, AXOR, KRAUS, GINGER, NEWPORT BRASS, BRASSTECH, WALTEC, BRISTAN, HERITAGE, MIROLIN, HÃPPE, HOT SPRING, CALDERA, FREEFLOW SPAS, FANTASY SPAS, ENDLESS POOLS, BRASSCRAFT, PLUMB SHOP, COBRA, COBRA PRO, and MASTER PLUMBER brands. The Decorative Architectural Products segment offers paints, primers, specialty coatings, stains, and waterproofing products, as well as paint applicators and accessories; cabinet and door hardware, functional hardware, wall plates, hook and rail products, closet organization systems, and picture hanging accessories; decorative bath hardware, mirrors, and shower accessories and doors; and decorative indoor and outdoor lighting fixtures, ceiling fans, landscape lighting, and LED lighting systems. This segment provides its products under the BEHR, KILZ, WHIZZ, Elder & Jenks, LIBERTY, BRAINERD, FRANKLIN BRASS, KICHLER, and ÃLAN brands. It sells its products to the plumbing, heating, and hardware wholesalers; home centers and online retailers; hardware stores; electrical and landscape distributors; lighting showrooms; building supply outlets; and other mass merchandisers. Masco Corporation was founded in 1929 and is headquartered in Livonia, Michigan.
Predictive Oncology Inc.
Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Helomics, Soluble, and Skyline. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' exposure to infectious fluids collected during surgical and other patient procedures, as well as proprietary cleaning fluid and filters to users of its systems. The company also provides contract research organization (CRO) and AI-driven predictive models of tumor drug response to improve clinical outcomes to assist pharmaceutical, diagnostic, and biotech industries; and soluble and stable formulations for proteins, including vaccines, antibodies, and other protein therapeutics, as well as develops tumor models for precision cancer therapy and drug development. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence (AI) applied to diseases databases. The company sells its medical device products directly to hospitals and other medical facilities through employed sales representatives, independent contractors, and distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.
Latest MAS
- SEC Form 11-K filed by Masco Corporation
- SEC Form SD filed by Masco Corporation
- Masco Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Masco Corporation Provides Strategic Update and Long-Term Financial Targets
- Director Stevens Charles K. Iii was granted 2,650 shares, increasing direct ownership by 17% to 18,090 units (SEC Form 4)
- Director Sandeep Reddy was granted 2,650 shares, increasing direct ownership by 34% to 10,460 units (SEC Form 4)
- Director Plant John C was granted 2,650 shares, increasing direct ownership by 6% to 50,574 units (SEC Form 4)
- Director Payne Lisa A was granted 2,650 shares, increasing direct ownership by 19% to 16,487 units (SEC Form 4)
- Director O'Herlihy Christopher A was granted 2,650 shares, increasing direct ownership by 5% to 51,766 units (SEC Form 4)
- Director Ffolkes Marie A was granted 2,650 shares, increasing direct ownership by 12% to 24,517 units (SEC Form 4)
Latest POAI
- SEC Form S-8 filed by Predictive Oncology Inc.
- Predictive Oncology Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Chief Executive Officer Vennare Raymond F covered exercise/tax liability with 2,373 shares, decreasing direct ownership by 27% to 6,418 units (SEC Form 4)
- Predictive Oncology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
- SEC Form EFFECT filed by Predictive Oncology Inc.
- Predictive Oncology Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 424B3 filed by Predictive Oncology Inc.
- SEC Form 424B3 filed by Predictive Oncology Inc.
- Predictive Oncology Inc. filed SEC Form 8-K: Other Events